Rebrin K, Steil G M, Getty L, Bergman R N
Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles 90033, USA.
Diabetes. 1995 Sep;44(9):1038-45. doi: 10.2337/diab.44.9.1038.
Overproduction of glucose by the liver in the face of insulin resistance is a primary cause of hyperglycemia in non-insulin-dependent diabetes mellitus (NIDDM). However, mechanisms involved in control of hepatic glucose output (HGO) remain less than clear, even in normal individuals. Recent results have supported an indirect extrahepatic effect of insulin as the primary locus of insulin action to restrain HGO. One suggested extrahepatic site is the pancreatic alpha-cell. To examine whether insulin's extrahepatic site is independent of the alpha-cells, HGO suppression was examined independent of changes in glucagon secretion or insulin antagonism of glucagon action. Euglycemic glucose clamps (n = 40) with somatostatin infusion were performed in conscious dogs (n = 5). Paired experiments were conducted in which insulin was infused either portally (1.2, 3.0, 6.0 pmol.min-1.kg-1) or peripherally at half the portal infusion rate (0.6, 1.5, 3.0 pmol.min-1.kg-1). Additional zero and saturating portal-dose experiments (100 pmol.min-1.kg-1) were also performed. For the paired experiments, portal insulin infusion resulted in portal insulin concentrations approximately two to three times higher than in the corresponding peripheral insulin infusion experiments, while at the same time peripheral insulin concentrations were approximately matched. Equal peripheral insulin concentration resulted in equivalent HGO suppression irrespective of the portal concentrations. Thus, insulin affects a signal at a peripheral site, other than alpha-cell, that in turn suppresses hepatic glucose production. To investigate the nature of this signal, we measured alanine, lactate, and free fatty acids (FFAs).(ABSTRACT TRUNCATED AT 250 WORDS)
在胰岛素抵抗情况下肝脏葡萄糖过度生成是非胰岛素依赖型糖尿病(NIDDM)患者高血糖的主要原因。然而,即使在正常个体中,肝脏葡萄糖输出(HGO)控制所涉及的机制仍不清楚。最近的研究结果支持胰岛素的间接肝外效应是抑制HGO的主要胰岛素作用位点。一个被认为的肝外位点是胰腺α细胞。为了研究胰岛素的肝外位点是否独立于α细胞,在不考虑胰高血糖素分泌变化或胰岛素对胰高血糖素作用的拮抗作用的情况下,对HGO抑制进行了研究。对清醒犬(n = 5)进行了持续输注生长抑素的正常血糖葡萄糖钳夹实验(n = 40)。进行了配对实验,分别以门静脉输注(1.2、3.0、6.0 pmol·min-1·kg-1)或外周输注(门静脉输注速率的一半,即0.6、1.5、3.0 pmol·min-1·kg-1)胰岛素。还进行了额外的零剂量和饱和门静脉剂量实验(100 pmol·min-1·kg-1)。对于配对实验,门静脉输注胰岛素导致门静脉胰岛素浓度比相应外周胰岛素输注实验高约两到三倍,而同时外周胰岛素浓度大致相当。外周胰岛素浓度相等时,无论门静脉浓度如何,均导致同等程度的HGO抑制。因此,胰岛素在α细胞以外的外周位点影响一个信号,进而抑制肝脏葡萄糖生成。为了研究该信号的性质,我们测量了丙氨酸、乳酸和游离脂肪酸(FFA)。(摘要截短于250字)